Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.12.2020 | editorial

Homologous recombination deficiency: New biomarkers in innovative treatments

verfasst von: Christian F. Singer, MD, MPH

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

Homologous recombination (HR) is a key DNA repair mechanism that is essential for maintaining genome stability. It is characterized by its high fidelity and efficiency, and represents the pivotal repair mechanism for DNA double-strand breaks. Although known for years, its potential role as a therapeutic target has only recently been elucidated: malignant breast and ovarian tumors with mutations in the breast cancer susceptibility genes BRCA1 and BRCA2, two genes that are quintessential members of the homologous recombination repair (HRR) pathway, have been demonstrated to be particularly sensitive to poly-ADP ribose polymerase inhibitors (PARPi), such as talazoparib and olaparib. In addition, BRCA-associated HR deficiency (HRD) renders tumors particularly sensitive to platinum-based chemotherapy. …
Nächster Artikel Treating head and neck cancer—A multidisciplinary effort
Literatur
1.
2.
3.
4.
Metadaten
Titel
Homologous recombination deficiency: New biomarkers in innovative treatments
verfasst von
Christian F. Singer, MD, MPH
Publikationsdatum
01.12.2020
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 4/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00660-7

Weitere Artikel der Ausgabe 4/2020

Transoral robotic surgery in head and neck cancer

  • short review

Fertility preservation in women with endometrial cancer

  • review

Molecular profiling in gastroesophageal cancer—clinical routine and future perspective

  • Open Access
  • short review

Homologous recombination deficiency in epithelial ovarian cancer

  • Open Access
  • short review

Fertility preservation procedures in girls, adolescents and women

  • Open Access
  • short review

Position statement of the Austrian Society for Hematology and Medical Oncology on the use of molecular diagnostics in solid tumors

  • consensus report